Achieving a deep response on patient-reported outcomes with upadacitinib in patients with moderate to severe atopic dermatitis: Results from three phase 3 trials

被引：0

作者：

Chovatiya, Raj ^{[1
]}

Schuttelaar, Marie-Louise ^{[2
]}

Calimlim, Brian ^{[3
]}

Liu, Yingyi ^{[3
]}

Takemoto, Shunya ^{[3
]}

Staender, Sonja ^{[4
,5
]}

机构：

[1] Northwestern Univ, Feinberg Sch Med, Dept Dermatol, Chicago, IL 60611 USA

[2] Univ Groningen, Groningen, Netherlands

[3] AbbVie Inc, N Chicago, IL USA

[4] Univ Hosp Munster, Dept Dermatol, Munster, Germany

[5] Univ Hosp Munster, Ctr Chron Pruritus, Munster, Germany

来源：

关键词：

D O I：

暂无

中图分类号：

R392 [医学免疫学];

学科分类号：

100102 ;

摘要：

P040

引用

页码：1017 / 1018

页数：2